UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Molecular pharmaceutics, ISSN 1543-8384, 08/2012, Volume 9, Issue 8, pp. 2358 - 2363
Salivary Excretion Classification System | effective permeability | pharmacokinetics | protein binding | bioequivalence | SimCYP | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Quinolines - blood | Acetates - blood | Fluorobenzenes - pharmacokinetics | Hydrochlorothiazide - pharmacokinetics | Triazoles - blood | Piroxicam - blood | Azithromycin - blood | Humans | Losartan - blood | Saliva - secretion | Male | Naphthalenes - blood | Benzhydryl Compounds - blood | Fluorobenzenes - pharmacology | Quinolines - pharmacokinetics | Sulfonamides - blood | Azithromycin - pharmacokinetics | Tolterodine Tartrate | Female | Triazoles - pharmacokinetics | Naphthalenes - pharmacokinetics | Piroxicam - analogs & derivatives | Sitagliptin Phosphate | Hydrochlorothiazide - blood | Losartan - pharmacokinetics | Benzhydryl Compounds - pharmacokinetics | Metformin - blood | Cresols - blood | Phenylpropanolamine - blood | Metformin - pharmacokinetics | Rosuvastatin Calcium | Cloxacillin - pharmacokinetics | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Sulfonamides - pharmacokinetics | Cinacalcet Hydrochloride | Cloxacillin - blood | Saliva - metabolism | Pyrazines - pharmacokinetics | Piroxicam - pharmacokinetics | Pyrimidines - pharmacokinetics | Cresols - pharmacokinetics | Anthraquinones - blood | Anthraquinones - pharmacokinetics | Phenylpropanolamine - pharmacokinetics | Pyrazines - blood | Acetates - pharmacokinetics | Index Medicus
Journal Article
Drug metabolism and disposition, ISSN 0090-9556, 04/2017, Volume 45, Issue 4, pp. 390 - 398
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Protein Kinase Inhibitors - pharmacokinetics | Rifampin - pharmacokinetics | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Administration, Oral | Area Under Curve | Humans | src-Family Kinases - antagonists & inhibitors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Ketoconazole - pharmacokinetics | Cytochrome P-450 CYP3A Inhibitors - pharmacokinetics | Treatment Outcome | Aniline Compounds - pharmacokinetics | Quinolines - administration & dosage | Nitriles - pharmacokinetics | Nitriles - administration & dosage | Quinolines - pharmacokinetics | Protein Kinase Inhibitors - administration & dosage | Drug Interactions | Cytochrome P-450 CYP3A - metabolism | Models, Biological | Computer Simulation | Cytochrome P-450 CYP3A Inducers - pharmacokinetics | Aniline Compounds - administration & dosage | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2011, Volume 55, Issue 10, pp. 4619 - 4630
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Fluoroquinolones | Aza Compounds - pharmacokinetics | Area Under Curve | Erythromycin - pharmacology | Escherichia coli - drug effects | Humans | Cefuroxime - pharmacology | Aza Compounds - pharmacology | Quinolines - pharmacology | Microbial Sensitivity Tests | Quinolines - pharmacokinetics | Anti-Bacterial Agents - therapeutic use | Gentamicins - pharmacology | Computer Simulation | Vancomycin - pharmacology | Streptococcus pyogenes - drug effects | Gentamicins - pharmacokinetics | Penicillin G - pharmacology | Erythromycin - pharmacokinetics | Cefuroxime - pharmacokinetics | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Penicillin G - pharmacokinetics | Index Medicus | Drugs | Subpopulations | Pharmacodynamics | Gentamicin | Benzylpenicillin | Erythromycin | Moxifloxacin | Regression analysis | Vancomycin | Drug development | Cefuroxime | Antibiotics | Minimum inhibitory concentration | Models | Pharmacokinetics | Experimental Therapeutics
Journal Article
Clinical pharmacology and therapeutics, ISSN 0009-9236, 2019, Volume 105, Issue 2, pp. 388 - 401
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Artemisinins - pharmacokinetics | Humans | Long QT Syndrome - chemically induced | Male | Quinolines - pharmacology | Dose-Response Relationship, Drug | Quinolines - pharmacokinetics | Artemisinins - pharmacology | Drug Interactions | Adult | Female | Insecticides - pharmacology | Antimalarials - pharmacokinetics | Double-Blind Method | Long QT Syndrome - epidemiology | Ivermectin - pharmacokinetics | Treatment Outcome | Ivermectin - pharmacology | Kenya | Antimalarials - pharmacology | Anopheles | Animals | Malaria - drug therapy | Drug Combinations | Insecticides - pharmacokinetics | Index Medicus | Abridged Index Medicus | Clinical Trial | Research
Journal Article
Clinical pharmacology and therapeutics, ISSN 0009-9236, 03/2017, Volume 101, Issue 3, pp. 406 - 415
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Organic Anion Transporters - antagonists & inhibitors | Cytochrome P-450 CYP2C8 - drug effects | Liver - metabolism | Rats | Gemfibrozil - pharmacology | Hepatocytes - metabolism | Organic Anion Transporters - metabolism | Quinolines - pharmacology | Haplorhini | Dose-Response Relationship, Drug | Quinolines - pharmacokinetics | Nucleic Acid Synthesis Inhibitors | Animals | Cytochrome P-450 CYP3A Inhibitors - metabolism | Models, Biological | Solute Carrier Organic Anion Transporter Family Member 1b1 - antagonists & inhibitors | Clarithromycin - pharmacokinetics | Acetates - pharmacology | Cytochrome P-450 CYP2C8 - metabolism | Rifampin - pharmacology | Acetates - pharmacokinetics | Care and treatment | Usage | Montelukast | Dosage and administration | Research | Drug therapy | Pharmacokinetics | Asthma | Index Medicus | Abridged Index Medicus
Journal Article
Clinical pharmacokinetics, ISSN 0312-5963, 10/2016, Volume 55, Issue 10, pp. 1191 - 1204
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Nitriles - pharmacology | Area Under Curve | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Half-Life | Metabolic Clearance Rate | Nitriles - pharmacokinetics | Intestinal Absorption | Quinolines - pharmacology | Dose-Response Relationship, Drug | Quinolines - pharmacokinetics | Liver Failure - metabolism | Drug Interactions | Electrocardiography | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacokinetics | Aniline Compounds - pharmacology | Clinical Trials as Topic | Renal Insufficiency - metabolism | Aniline Compounds - pharmacokinetics | Asian Continental Ancestry Group | Cytochrome P-450 CYP3A - metabolism | Protein Binding | Protein Kinase Inhibitors - pharmacology | Quinolines - therapeutic use | Aniline Compounds - therapeutic use | Nitriles - therapeutic use | Index Medicus
Journal Article
Journal of clinical pharmacology, ISSN 0091-2700, 08/2011, Volume 51, Issue 8, pp. 1152 - 1162
Population pharmacokinetics | QT prolongation | exposure—response modeling | thorough QT studies | ICH E14 | moxifloxacin | exposure-response modeling | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Fluoroquinolones | Aza Compounds - pharmacokinetics | Quinolines - blood | Drugs, Investigational - adverse effects | Anti-Infective Agents - blood | United States | Humans | Middle Aged | Drugs, Investigational - pharmacokinetics | Aza Compounds - adverse effects | Male | Metabolic Clearance Rate | Quinolines - administration & dosage | Drugs, Investigational - analysis | Intestinal Absorption | Delayed-Action Preparations - administration & dosage | Quinolines - pharmacokinetics | Young Adult | Delayed-Action Preparations - pharmacokinetics | Adult | Aza Compounds - blood | Female | United States Food and Drug Administration | Aza Compounds - administration & dosage | Anti-Infective Agents - adverse effects | Administration, Oral | Electrocardiography - drug effects | Clinical Trials as Topic | Animals | Anti-Infective Agents - administration & dosage | Delayed-Action Preparations - adverse effects | Models, Biological | Anti-Infective Agents - pharmacokinetics | Adolescent | Drugs, Investigational - administration & dosage | Aged | Quinolines - adverse effects | Physiological aspects | Moxifloxacin | Research | Demographic aspects | Pharmacokinetics | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 03/2016, Volume 22, Issue 6, pp. 1385 - 1394
Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Quinolines - pharmacokinetics | Neoplasm Metastasis | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Female | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacokinetics | Phenylurea Compounds - pharmacokinetics | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Treatment Outcome | Combined Modality Therapy | Magnetic Resonance Imaging | Retreatment | Carcinoma, Hepatocellular - pathology | Aged | Quinolines - therapeutic use | Neoplasm Staging | Quinolines - adverse effects | Index Medicus
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 11/2019, Volume 84, Issue 5, pp. 1003 - 1015
Pharmacodynamics | Medicine & Public Health | Anticancer drugs | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacokinetics | Randomized controlled trial | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Deoxycytidine - administration & dosage | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Half-Life | Male | Quinolines - administration & dosage | Randomized Controlled Trials as Topic | Pancreatic Neoplasms - drug therapy | Young Adult | CA-19-9 Antigen - metabolism | Pyrazoles - administration & dosage | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Deoxycytidine - analogs & derivatives | Statistical analysis | Gemcitabine | Transforming growth factor | Exposure | Pharmacology | Dosage | Patients | Survival | Survival analysis | Pancreatic cancer | Growth factors | Cancer | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2011, Volume 55, Issue 2, pp. 649 - 658
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Fluoroquinolones - chemistry | Aza Compounds - pharmacokinetics | Anti-Infective Agents - pharmacology | Humans | Monocytes - metabolism | Aza Compounds - pharmacology | Fluoroquinolones - pharmacokinetics | Quinolines - pharmacology | Microbial Sensitivity Tests | Quinolines - pharmacokinetics | Anti-Infective Agents - chemistry | Staphylococcal Infections - microbiology | Culture Media - chemistry | Staphylococcus aureus - metabolism | Cell Line | Monocytes - microbiology | Quinolines - chemistry | Aza Compounds - chemistry | Macrophages - metabolism | Animals | Models, Biological | Anti-Infective Agents - pharmacokinetics | Fluoroquinolones - pharmacology | Mice | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Index Medicus | Susceptibility
Journal Article